Australian industry attacks govt's price proposal
This article was originally published in Scrip
Executive Summary
The Australian government's plans for bringing down off-patent drug prices by removing originator brands from the price calculations have not gone down well with the pharmaceutical industry, which claims the move could jeopardize the supply of certain medicines.